Astellas Pharma Inc (ALPMY)

14.13 -0.17  -1.17% OTC Markets Oct 22, 12:51 USD
View Full Chart
Price Chart
View All ALPMY News


View All Events


Date Type Description
03/27/2020 Dividends Amount: 0.1862, Declared Date: Mar 27 2020, Pay Date: Jun 15 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL: N/A
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Mar. 27, 2020
  • Description: Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Top Fund Holders

Symbol Name Weighting
FTTAFX FT Pharmaceutical Select 41 RE 3.60%
F0000152QD FT Pharmaceutical Select 40 F RE 3.40%
GTCIX Glenmede Quant International Equity 2.94%
FDAOEX FT Strategic International Opp 14 RE 1.78%
JINTX Johnson International 1.49%
F0000156KG FT Strategic International Opp 13 F RE 1.40%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.